Biology Reference
In-Depth Information
[139] Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of
age. Blood 2006;108(5):1435-40.
[140] Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Im-
munol 1992;148(4):1143-8.
[141] Moore KW, O'Garra A. de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu
Rev Immunol 1993;11:165-90.
[142] Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth.
Blood 1993;81(11):2964-71.
[143] Huber S, Gagliani N, Esplugues E, O'Connor Jr W, Huber FJ, Chaudhry A, et al.
Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+
regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity
2011;34(4):554-65.
[144] Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3+ CD25+ CD4+
natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immu-
nol Rev 2006;212:8-27.
[145] Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required
for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med
2001;193(11):1311-8.
[146] Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)
CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood
2002;99(10):3493-9.
[147] Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, et al. Altered
regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic
hematopoietic stem cell transplantation. J Clin Invest 2010;120(5):1479-93.
[148] Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency
of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host
disease. Blood 2005;106(8):2903-11.
[149] Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, et al. Mucosal FOXP3+
regulatory T cells are numerically deficient in acute and chronic GvHD. Blood
2006;107(4):1717-23.
[150] Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic
self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:
induction of autoimmune disease by breaking their anergic/suppressive state. Int
Immunol 1998;10(12):1969-80.
[151] Cooke KR, Ferrara JL. A protective gene for graft-versus-host disease. N Engl J Med
2003;349(23):2183-4.
[152] Rowe V, Banovic T, MacDonald KP, Kuns R, Don AL, Morris ES, et al. Host B cells
produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow
transplantation. Blood 2006;108(7):2485-92.
[153] Tawara I, Sun Y, Liu C, Toubai T, Nieves E, Evers R, et al. Donor- but not host-derived
interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J
Leukocyte Biol 2012;91(4):667-75.
[154] Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an inter-
leukin-10 promoter polymorphism to graft-versus-host disease and survival after
hematopoietic-cell transplantation. N Engl J Med 2003;349(23):2201-10.
[155] Lin MT, Storer B, Martin PJ, Tseng LH, Grogan B, Chen PJ, et al. Genetic variation in the
IL-10 pathway modulates severity of acute graft-versus-host disease following hema-
topoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10
receptor beta genotype of donor. Blood 2005;106(12):3995-4001.
[156] Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor re-
ceptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med
2000;191(7):1233-40.
[157] McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al.
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-
17 cell-mediated pathology. Nat Immunol 2007;8(12):1390-7.
[158] McGeachy MJ, Cua DJ. The link between IL-23 and Th17 cell-mediated immune pa-
thologies. Semin Immunol 2007;19(6):372-6.
[159] Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al.
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T
helper type 1 and 2 lineages. Nat Immunol 2005;6(11):1123-32.
[160] Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, et al. Cutting edge:
IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J
Immunol 2006;177(5):2760-4.
[161] Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-
differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe
cutaneous and pulmonary pathologic manifestations. Blood 2009;113(6):1365-74.
388
Search WWH ::
Custom Search